Progress-free and overall survival based on flow MRD status with frontline CFAR. Kaplan-Meier analyses showing progression-free survival from start of treatment by 3-color flow cytometry BM residual disease (MRD flow) status (negative, solid line; positive, dashed line) after course 3 (A) and at end of treatment (B). Overall survival is shown from start of treatment by 3-color flow cytometry BM residual disease (negative, solid line; positive, dashed line) status at end of treatment (C).